Exposed nucleoprotein inside rabies virus particle as an ideal target for real-time quantitative evaluation of rabies virus particle integrity in vaccine quality control
PLOS Neglected Tropical Diseases · 2025
DOI: 10.1371/journal.pntd.0013077 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Jia Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Institutes for Food and Drug Control, Beijing, China. Hauptthemen laut MEDLINE: Rabies virus, Rabies Vaccines, Nucleoproteins, Virion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Municipal Science and Technology Plan Project, State Key Laboratory of Drug Regulatory Science Project.
Abstract (Originalsprache)
Currently, the integrity of rabies virus particle in quality control can only be assessed through electron microscopy. However, its time-consuming nature, operational complexity, limited accuracy and lack of quantification capability no longer meet the needs of modern vaccine production. Based on this, we developed a time-resolved fluoroimmunoassay (TRFIA) to enable real-time quantitative analysis of rabies virus particle integrity in human rabies vaccine, by detecting exposed nucleoprotein. Monoclonal antibodies against rabies glycoprotein and nucleoprotein were prepared using the classical hybridoma technology with the aim of constructing a novel detection approach for assessing particle integrity. A monoclonal antibody against rabies glycoprotein was immobilized on microplate wells to capture rabies virus particles, while a labeled antibody against the nucleoprotein served as the signal tracer. Multiple types of vaccine samples were analyzed to evaluate the effectiveness and accuracy of the developed TRFIA, combined with various virus particle destruction methods to validate its capability to assess particle integrity. The validation results were consistent with those obtained from electron microscopy. Therefore, this novel TRFIA offers a promising solution to address existing gaps in current analytical methods, enabling straightforward real-time, and quantitative evaluation of rabies virus particle integrity in the laboratory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Institutes for Food and Drug Control, Beijing, China.
- State Key Laboratory of Drug Regulatory Science, Beijing, China.
- Institute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
- Medical Big Data Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong Province, China.
ORCID-Profile: Guanfeng Lin
Förderung
- Guangzhou Municipal Science and Technology Plan Project
- State Key Laboratory of Drug Regulatory Science Project
Zitieren
APA
Li, J., Yang, Y., Jia, K., Zhang, Z., Zhai, X., Cao, Y., Huang, X., Cao, S., Wu, Y., & Lin, G. (2025). Exposed nucleoprotein inside rabies virus particle as an ideal target for real-time quantitative evaluation of rabies virus particle integrity in vaccine quality control. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013077
Vancouver
Li J, Yang Y, Jia K, Zhang Z, Zhai X, Cao Y, et al. Exposed nucleoprotein inside rabies virus particle as an ideal target for real-time quantitative evaluation of rabies virus particle integrity in vaccine quality control. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013077
BibTeX
@article{Li2025,
author = {Li, Jia and Yang, Yuhang and Jia, Kuangrou and Zhang, Zhigao and Zhai, Xiangmin and Cao, Yue and Huang, Xinbiao and Cao, Shouchun and Wu, Yingsong and Lin, Guanfeng},
title = {Exposed nucleoprotein inside rabies virus particle as an ideal target for real-time quantitative evaluation of rabies virus particle integrity in vaccine quality control},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
doi = {10.1371/journal.pntd.0013077}
}
EUVIMED